Luster, M. I. , Portier, C. , Pait, D. G. , White, K. L., Jr. , Gennings, C. , Munson, A. E. & Rosenthal, G. J. (1992) Fundam. Appl. Toxicol.18, 200-210 .
2.
Luster, M. I. , Portier, C. , Pait, D. G. , Rosenthal, G. J. , Germolec. D. R. , Corsini, E. , Blaylock, B. L. , Pollock, P. , Kouchi, Y. , Craig, W. , White, D. L. , Munson, A. E. & Comment, C. E. (1993) Fundam. Appl. Toxicol.21, 71-82 .
3.
Selgrade, M. J. K. (1998) Toxicol. In Press.
4.
Kimber, I. , Dearman, R. J. , Scholes, E. W. & Basketter, D. A. (1994) Toxicology93, 13-31 .
5.
Hilton, J. , Dearman, R. J , Boylett, M. S. , Fielding, I. , Basketter, D. A. & Kimber, I. (1996) J. Appl. Toxicol.16, 165-170
6.
Kimber, I. & Dearman, R. J. (1997) Clin. Rev. Allergy Immunol.15, 145-168
7.
Dearman, R. J. , Basketter, D. A. & Kimber, I. (1996) TOxicol. Appl. Pharmacol.138, 308-316 .
8.
Report of a WHO Scientific Group (1997). Clin.Exp.Immunol.109, Suppl. 1, 1-28 .
9.
Rosen, F. S. , Cooper, M. D. & Wedgwood, R. J. P. (1995). New Eng. J. Med.333, 431-440 .
10.
Fischer, A. , De Saint Bastille, G. , Disanto J. R , et al (1997) Adv. Nephrol.26, 107-120 .
11.
Matsuzawa T. , Hashimoto M. , Nara H. , Yoshida M. ., Tamura S. and Igarashi T. (1997) In Current Status of Conducting Function Tests in Repeated Dose Toxicity Studies in Japan Journal of Toxicological Sciences: 22 (5): 375-382 (1997)
12.
Herber R. F. M. (1996) Toxicokinetics and Toxicodynamics - I. In Fundamental Toxicology for Chemists ed. Duffus J. H. and Worth H. G. J. pp. 17-25The Royal SOciety of Chemistry
13.
Boyett, M. R. , Harrison, SM. , Janvier, N.et al. (1996) Cardiovasc. Res.32, 455-481 .
14.
Noma, A. (1996) Jpn Heart J.37, 673-682 .
15.
Doll, R. & Peto, R. (1981) J. Natl. Cancer Inst.66, 1191-1309 .
16.
Lutz, W. K. & Schlatter, J. (1992) Carcinogenesis13, 2211-2216 .
17.
Hart, R. W. , Neumann, D. A. & Robertson, R. T. , eds. (1995) Dietary Restriction: Implications for the Design and Interpretation of Toxicity and Carcinogenicity Studies. 396-396 pp. Washington DC: ILSI Press .
Kakiuchi, H.et al. , Proc. Natl. Acad. Sci. USA, 92, 910-914 (1995)
22.
Dashwood, R. H.et al. , Cancer Res., in press
23.
Mirvish, S. S. (1995) Cancer Lett.93, 17-48
24.
Correa, P. (1992) Cancer Res.52, 6735-6740
25.
Bingham, S. A. , Pignatelli, B. , Pollock, J. , Ellul, A. , Mallaveille, C. , Gross, G. , Runswick, S. , Cummings, J. H. , & O'Neill, I. K. , (1996) Carcinogenesis.17, 515-523
26.
Sedgwick, B. (1997) Carcinogenesis.18, 1561-1567
27.
Challis, B. C. (1989) Cancer Surveys, 8, 363-384
28.
Shuker, D. E. G. , & Margison, G. P. , (1997) Cancer Res.57, 366-369
29.
Harrison, K. L. , Fairhurst, N. , Challis, B. C. , & Shuker, D. E. G. , (1997) Chem. Res. Tox., 10, 652-659
30.
Harrison, K.L., Jukes, R., Cooper, D.P., & Shuker, D.E.G., Manuscript in preparation.
31.
Harrison, K.L., & Shuker, D.E.G., Manuscript in preparation
32.
Halliwell, B. (1996) Free Rad. Res.25, 57-74 .
33.
Jenner, A. , England, T. G. , Aruoma, O. I. and Halliwell, B. (1998) Biochem. J. in press.
34.
Block, G. , Patterson, B. , & Subar, A. (1992) Nutr. Cancer, 18, 1-29 .
35.
Huttunen, J. K. (1996) In: Chemoprevention in Cancer Control.' Eds. Hakama, M. , et al., IARC Publication. pp 63-65. Lyon .
36.
Hayes, J. H. , Ellis, E. M. , Neal, G. E. , Harrison, D. J. & Manson, M. M. (1998) In `Cellular Stress Responses' Eds Downes, C. P. & Wolf, C. R. , Portland Press, London , (in press)
37.
Gescher, A. , Pastorino, U. , Plummer, S. M. , & Manson, M. M. (1998) Brit. J. Clin. Pharmacol.45, 1-12 .
38.
Brown, N. A.et al. (1995) ATLA23, 868-882
39.
ICH Harmonised Tripartite Guideline: Reproductive Toxicity (1993)
EPA 540/07-91-123 Series 83-6: Developmental Neurotoxicity Study (1991)
43.
Maden, M. (1998) In Retinoids: Handbook of Experimental Pharmacology eds. Nau, H. & Blaner, W. S. (in press). Heidelberg: Springer-Verlag .
44.
Lammer, E. J. & Armstrong, D. L. (1992) In Retinoids in Normal Development and Teratogenesis ed. Morriss-Kay G. pp281-295, Oxford: Oxford University Press .
45.
Gale, E. , Prince, V. , Lumsden, A. , Clarke, J. , Holder, N. & Maden, M. (1996) Development122, 783-793 .
46.
Maden, M. , Gale, E. , Kostetskii, I. & Zile, M. H. (1996) Current Biol.6, 417-426 .
47.
Bernfield, M. (1990). Developmental biology: Preventive medicine for neonatology . Pediatr. Res.27(Suppl), S21-S27 .
48.
Copp, A. J. (1994). Birth defects - from molecules to mechanisms . J. Roy. Coll. Phys.28, 294-300 .
49.
Fleming, A. , Gerrelli, D. , Greene, N. D. E. & Copp, A. J. (1997). Mechanisms of normal and abnormal neurulation: evidence from embryo culture studies . Int. J. Dev. Biol.41, 199-212 .
50.
Copp, A. J. & Bernfield, M. (1994). Etiology and pathogenesis of human neural tube defects: Insights from mouse models . Curr. Opin. Pediatr.6, 624-631 .
51.
Wald, N. , Sneddon, J. , Densem, J. , Frost, C. , Stone, R. & MRC Vitamin Study Res Group . (1991). Prevention of neural tube defects: Results of the Medical Research Council Vitamin Study . Lancet338, 131-137 .
52.
Greene, N. D. E. & Copp, A. J. (1997). Inositol prevents folate-resistant neural tube defects in the mouse . Nature Med.3, 60-66 .
53.
Morgane PJ , Austin-LaFrance RJ , Bronzino JD , Tonkiss J & Galler JR (1992) Malnutrition in the developing central nervous system. In: The vulnerable brain and environmental risks, Plenum Press .
54.
Rodier PM (1994) Comparative postnatal neurological development. In Prenatal Exposure to Neuroteratogens. Johns Hopkins University Press .
55.
Rosengarten H & Friedhoff AJ (1979) Enduring changes in dopamine receptors of pups from drug administration to pregnant and nursing rats . Science203, 1133-1135 .
56.
Tikkanen, M. J. , Wähälä, K. , Ojala, S. , Vihma, V. & Adlercreutz, H. (1998) Proc. Natl. Acad. Sci., in press.
57.
Adlercreutz, H. & Mazur, W. (1997) Ann. Med.29, 95-120 .
58.
Guengerich, F. P. (1995) In Cytochrome P450 ed. Ortiz de Montellano, P. R. pp. 473-535. New York: Plenum .
59.
Guengerich, F. P. , Gillam, E. M. J. & Shimada, T. (1996) Crit. Rev. Toxicol.26, 551-583 .
60.
Parikh, A. , Gillam, E. M. J. & Guengerich, F. P. (1997) Nature Biotechnol.15, 784-788 .
61.
Josephy, P. D. , Evans, D. H. , Parikh, A. , & Guengerich, F. P. (1998) Chem. Res. Toxicol.11, 70-74 .
62.
Bell, L. C. & Guengerich, F. P. (1997) J. Biol. Chem.272, 29643-29651 .
63.
Gonzalez, F. J. & Gelboin, H. V. (1993). J. Toxicol. Envron. Health40, 289-308 .
64.
Gonzalez, F. J. & Gelboin, H. V. (1994). Drug Metab. Rev.26, 165-183 .
65.
Crespi, C. L. , Gonzalez, F. J. , Steimel, D. T. , Turner, T. R. , Gelboin, H. V. , Penman, B. W. & Langenbach, R. (1991). Chem. Res. Toxicol.4, 566-572 .
66.
Crespi, C. L. (1995). Advances in Drug Research. ( Meyer, U. A. and Testa, B. Eds.) Academic Press, New York . 179-235.
67.
Smith, G. , Stanley, L. A. , Sim, E. , Strange, R. C. & Wolf, C. R. (1995) Cancer Surveys25, 27-65 .
68.
Tucker, G. T. (1994) J. Pharmac. Pharmacol.46, 417-424 .
69.
Hainzl, D. & Casida, J. E. (1996) Proc. Natl. Acad. Sci. USA, 93, 12764-12767
70.
Mahajna, M.Quistad, G. B. & Casida, J. E. (1997) Chem. Res. Toxicol., 10, 64-69
71.
Mahajna, M. & Casida, J. E. (1998) Chem. Res. Toxicol.11, 26-34
72.
Chao, S. L. & Casida, J. E. (1997) Pestic. Biochem. Physiol., 58, 77-88
73.
Fang, N. , Rowlands, J. C. & Casida, J. E. (1997) Chem. Res. Toxicol., 10, 853-858
Marrs T. C. (1996) Toxic Substance Mechanisms15, 357-388 .
83.
Niven K.J.M., Scott A.J., Hagen S., Waclawski E.R., Lovett M., et al (1993) Institute of Occupational Medicine Technical Memorandum TM/93/03.
84.
Rees H. (1996) Occup & Environ Med53, 258-263 .
85.
Stephens R. , Spurgeon A. , Calvert I. A. , Beach J. , Levy L. S. , et al (1995) Lancet345, 1135-1139 .
86.
Beach J. R. , Spurgeon A. , Stephens R. , Heafield T. , Calvert I. A. , et al (1996) Occup Environ Med53, 520-525 .
87.
Behan P. O. (1996) J Nut Env Med6, 341-350
88.
Hokkanen, H. M. T. & Lynch, J. M. (eds) (1995) Biological Control: Benefits and Risks. Cambridge University Press .
89.
Lynch, J. M. & Wiseman, A. (eds) (1998) Environmental Biomonitoring: The Biotechnology Ecotoxicology Interface. Cambridge University Press .
90.
Peroutka, S. J. (1987) New.Eng.J.Med.317, 1542-1543 .
91.
Henry, J. A. , Jeffreys, K. J. , Dawling, S. (1992) Lancet.340, 384-387 .
92.
Maxwell, D. L. , Polkey, M. J. , & Henry, J. A. (1993) British Medical Journal.307, 1399-1399 .
93.
Holden, R. , Jackson, M. A. (1996) Lancet.347, 1052-1052 .
94.
Iovino, M. , Steardo, L. (1985) European Journal of Pharmacology. 133, 99-103 .
95.
McElhatton, P. R. , Bateman, D. N. , Evans, C. , Pughe, K. R. , & Worsley A. J.Br J Clin Pharmacol.45, 184-184 .
96.
McGuire, P. K. , Cope, H. , Fahy, T. A. (1994) Br J Psych.165, 391-395 .
97.
Green, R. A. , Cross, A. J. , & Goodwin, G. M. (1995). Psychopharmacol.119, 247-260 .
98.
Substance Abuse . A comprehensive textbook. 3rd Edition. Eds. Lowinson JH , Ruiz P.Millman RB , Langrod JG.London Williams and Wilkins . 1997.
99.
Drummer OH , Opeskin K , Syrjanen M , Cordner S.Methadone toxicity causing death in ten subjects starting on a methadone maintenance program . Am J Forensic Med Pathol1992; 13: 346-350 .
100.
Clark JC , Milroy CM , Forrest ARWF.Deaths from methadone use . Journal of Clinical Forensic Medicine.
101.
1,2 Potten, CS and Loeffler M 1990 (Development 110, 1001-1019)
102.
Potten, CS , Booth C and Pritchard MInt. J. Exp. Path. 199778219-243
103.
Cai, W , Roberts, SA and Potten, CS.Int. J. Rad. Biol.199771573-579
104.
Overturf, K. , Al-Dhalimy, M. , Ou, C-N. , Finegold, M. & Grompe, M. (1997) Am J. Path.151, 1273-1280 .
105.
Alison, M. R. , Golding, M. , Sarraf, C. E. , Edwards, R. J. & Lalani, E-N. (1996) Gastroenterology110, 1182-1190 .
106.
Alison, M. R. , Golding, M. & Sarraf, C. E. (1997) Int. J. Exp. Path.78, 365-381 .
107.
Simpson, M. G. , et al , (1996) Neurotoxicology, 17, 471-480 .
108.
Widdowson, P. S. , et al (1996) Toxicol. Appl. Pharmacol.136, 57-66 .
109.
Lock, E. A. , et al , (1997) Toxicology123, 41-51
110.
Akazawa, C. , et al (1994) J. Comp. Neurol.347, 150-160 .
111.
Gibson, G. G. , Orton, T. C. , and Tanburini, P. P. (1982) Biochem J.325:203, 161-168 .
112.
Nelson, D. R. , Koymans, L. , Kamataki, T. , et al (1996) Pharmacogenetics6, 1-42 .
113.
Neng, Y. M. , Kuo, C-W. S. , Jones, P. S. , et al (1997) Biochem J.325: 741-749 .
114.
Kellerman, G. , Luyten-Kellerman, M. and Shaw, C. (1973) Amer. J. Hum. Genet.25, 327-331 .
115.
Kellerman, G. , Shaw, C. and Luyten-Kellerman, M. (1973) N. Engl. J. Med.298, 934-937 .
116.
Kouri, R. E. , McKinney, C. E. , Slomiany, D. J. , Snodgrass, D. R. , Wray, N. P. and McLemore, T. L. (1982) Cancer Res.42, 5030-5037 .
117.
Kawajiri, S. , Watanabe, J. , Eguchi, H. , Nakachi, K. , Kiyohara, C. and Hayashi, S. (1995) Pharmacogenetics.5, 152-258 .
118.
Jongen, W. F. M. & Dorgelo, F. O. (1986) Neth. J. Agric. Sci.34: 395-404
119.
Musonda, C. A. , Helsby, N. & Chipman, J. K. (1997) Hum. Exp. Toxicol. 16; 700-708
120.
Chipman, J. K. , Davies, J. E. & Dash, P. (1995) Proc. B. P. S.40: 193P-193P
121.
Derby, L. E. , Hershel, J. , Henry, D. A. & Dean, A. D. (1993) Med. J. Aust.158, 596-600 .
122.
Maria, V. A. , Pinto, L. , & Victorino, R. M. M. (1994) J. Hepatol.21, 151-158 .
123.
Park, B. K. , Coleman, J. W. & Kitteringham, N. R. (1987) Biochem. Pharmacol.36 (5), 581-590 .
124.
Szymkowski, D. E. (1996) Drug Discov. Today1, 415-428
125.
Stein, C. A. & Cheung, Y-C. (1993) Science261, 1004-1012
126.
Sarmiento, U. , Perez, J. R. , Becker, J. M. & Narayanan, R. (1994) Antisense Res. & Dev.4, 99-107
127.
Enk, A. H. & Katz, S. I. (1992) Proc. Natl. Acad. Sci. USA89, 1398-1402
128.
Dearman, R. J. , Basketter, D. A. & Kimber, I (1996) Toxicol. Appl. Pharmacol.138, 308-316 .
129.
Robinson, M. K , Babcock, L. S. , Horn, P. A. and Kawabata, T. T. (1996) Fund. and Appl. Tox.34, 15-24 .
130.
Juniper, C. P. and Roberts, D. M. (1984) J. Soc. Occup Med.34, 127-132 .
131.
Robinson, M. K , Babcock, L. S. , Horn, P. A. and Kawabata, T. T. (1996) Fund. and Appl. Tox.34, 15-24 .
132.
Sarlo, K. , Fletcher, E. R. , Gaines, W. G. and Ritz, H. L. (1997) Fund. and Appl. Tox.39, 44-52 .
133.
Atkinson, H. A. C. and Miller, K. (1994) Toxicology, 91, 281-288 .
134.
Atkinson, H. A. C. , Johnson, I. T.Gee, J. M. , Grigoriadou, F , and Miller, K. (1996). Fd. Chem. Toxicol.34 (1) 27-32 .
135.
Tanget al , (1996) Journal of Immunology, 157: 117-125
136.
Dearmanet al , (1997) Journal of Applied Toxicology, 17: 53-62
137.
Toth, B. & Boreisha, I. (1969). Eur. J. Cancer, 5, 165-171 .
138.
Schmahl, D. , Port, R. & Wahrendorf (1977). Int. J. Cancer19, 77-85 .
139.
Slaga, T. J. , Bowden, G.et al. (1974) Cancer Res.34, 771-777 .
140.
Ingram, A. & Grasso, P. (1977). Exp. Pathol.14, 233-242 .
141.
Schulte-Hermann, R. (1974). CRC Crit. Rev. Toxicol.3, 97-197
142.
Kaufmann, K. W. & Kaufman, D. G. (1993). FASEB7, 1188-1191 .
143.
IARC Monographs (1987) S7, 100-106
144.
Hoag W. G. (1963) Ann. NY Acad. Sci.108, 805-831
145.
Myers, D. D. , Meier, H. & Huebner R. J. (1970) Life Sciences.9(II), 1071-1080
146.
Adkison D. L. & Sundberg J. P. (1991) Vet. Pathol.28, 305-312
147.
Ohtani, I. , Moore, R. E. and Runnegar, M. T. C. (1992) J. Am. Chem. Soc.114, 7941-7942
148.
Hawkins, P. R. , Runnegar, M. T. C. , Jackson, A. R. B. and Falconer, I. R. (1985) Appl. Environ. Microbiol.50, 1292-1295
149.
Seawright, A. A. , Nolan, C. C. , Shaw, G. R. , Chiswell, R. K. , et al. (1998). Environ. Toxicol. and Water Qual (in press).
150.
Messina, M. J. , Persky, V. , Setchell, K. D. & Barnes, S. (1994) Nutr. Cancer21, 113-131
151.
Graichen, M. E. , Neptun, D. A. , Dent, J. G. , Popp, J. A. & Lennard, T. B. (1985). Fundament Appl. Toxicol., 5, 165-174 .
152.
Lijinsky, W. , Reuber, M. D. & Blackwell, B.-N. (1980). Science, 209, 817-819 .
153.
R. Caldwell & H. Challenger . Ann. of Clin. Biochem.26: 430-443 (1989).
154.
Substance Abuse and Mental Health Services Administration (1994) Federal Register59 (110), 29903-29903
155.
Rolfe, M. , James, N. H. and Roberts, R.A (1997) Tumour necrosis factor α (TNFα) suppresses apoptosis and induces DNA synthesis in rodent hepatocytes: a mediator of the hepatocarcinogenicity of peroxisome proliferators ? Carcinogenesis18, 2277-2280 .
156.
Cohen S D & Khairallah E A (1997) Drug Met. Revs, 29 (1-2): 59-77
157.
Roberts D Wet al. (1991) Am J. of Pathol.138 (2): 359-371
158.
Shen, W (1991) Toxicol. Appl. Pharmacol.111, 242-254
159.
Ray, S. D. , Mumaw, V. R. , Raje, R. R. & Fariss, M. W. (1996) J. Pharmacol. Exp. Ther.279, 1470-1483
160.
Charlottle, F. , L'Hermine, A. , Martin, N. , Geleyn, Y. , Nollet, M. , Gaulard, P. & Zafrani, E. S. (1994) Am. J. Pathol.144, 460-465
161.
Skopelitou, A. , Hadjlyannakis, M. , Alexopoulou, V. , Krikoni, O. , Kamina, S. & Agnantis, N. (1996) Anticancer Res.16, 975-978
162.
Kaufmann, S. H. , Desnoyers, S. , Ottaviano, Y. , Davidson, N. E. & Poirer, G. G. (1993) Cancer Res53, 3976-3985
163.
Badger, G. A. , Kuester, R. K. , Sauer, J-M and Sipes, I. G. (1997) Toxicology121, 143-153
164.
Leatham, E. W. , Holt, D. W. and McKenna, W. J. (1993). Class III antiarrhtmics in overdose: Presenting features and management principles . Drug Safety, 9, 450-462 .
165.
Hutchings, A. , Spragg, B. P. , and Routledge, P. A. (1986). High performance liquid chromatographic assay of amiodarone and desethyl amiodarone in plasma . Journal of Chromatography, 383, 389-393 .
166.
Evans, D. A. P. (1996) J. med. Genet.6, 405-407 .
167.
Şardaş, S. , Karakaya, A. E. and Çok, I. (1986) Clin. Genet.29, 185-186 .
168.
Şardaş, S. , Pontin, J. and Idle, J. R. (1991) Pharmacogenetics1, 123-124 .
169.
Karakaya,A. E. , Çok,i. , Şardaş, S. , Gögüş, O and Şardaş, O. S. (1986) Human Toxicol.5, 333-335 .
170.
Şardaş, S. , Karakaya,A. E. and Şardaş,O. S. (1986) Arthiritis Rheum29, 1412-1413 .
171.
Şardaş, S. , Çok,I. , Şardaş,O. S. , Ilhan, O. and Karakaya,A. E. (1990) Int.J.Cancer46, 1138-1139 .
172.
Şardaş, S. , Akyol,D. , Green,R. L. , Mellon,T. , Gökmen,O. and Cholerton S. (1996) Pharmacogenetics6, 459-463 .
173.
Ashby J.et al. (1982) Mutat. Res.93, 67-81 .
174.
Ashby J.et al. (1985) Mutat. Res.156, 1-18 .
175.
Ashby J. unpublished data.
176.
Brown E. V. & Sanchorawala C. J. (1968) J. Med. Chem.11, 1074-1075 .
177.
Elliott B. M.et al. (1983) Cancer Lett.21, 69-76 .
178.
Brinkschulte, M. , Gaertner, H. J. , Schied, H. W. & Breyer-Pfaff, H. (1982) Eur. J. Clin. Pharmacol.22, 367-373
179.
Pentel, R. P. & Benowitz, N. L. (1986) Medical Toxicology1, 101-121
180.
Kremer, J. M. , Wilting, J. & Janssen, L. H. (1988) Pharmacology Reviews40, 1-47
181.
van Luyn, M. J. A. , van Wachem, P. B. , Olde Damink, L. H. , Dijkstra, P. J. , Feijen, J. & Nieuwenhuis, P. (1991) J. Mater. Sci.2, 142-148
182.
Billi, B. , Lesnoni, G. , Scassa, C. , Giuliano, M. A. , Coppe, A. M. & Rossi, T. (1995) Eur. J. Ophthalmol.5, 235-239
183.
Virata, S. R. , Kylstra, J. A. & Pfeiffer, R. L. (1995) Ophthalmic Surg.26, 142-144
184.
Spooncer, E. , Boettiger, D. and Dexter, T. M. (1984) Nature310228-230 .
185.
Liebmann, J. E. , Hahn, S. M. , Cook, J. A. , Lipschultz, C. , Mitchell, J. B. and Kaufman, D. C. (1993) Cancer Research53(9) 2066-2070 .
186.
Raucy, J. L. , Kraner, J. C. , and Lasker, J. M. (1993) Critical Reviews in Toxicology, 23, 1-20 .
187.
Ferrara, R. , White, I. N. H. , and Manno, M. (1996) Toxicology Letters, Supplement 1/88, PID-156-PID-156
188.
Wang, B. H. , Zuzel, K. A. , Rahman, K. & Billington,D. (1998) Toxicology (in press).
189.
Azer, S. A. & Stacey, N. H. (1994) Toxiciol. Appl. Pharmacol.124, 302-309 .
190.
Boukamp,P. , Petrussevska,R. T. , Breitkreutz,D. , Hornung,J. , Markham,A. & Fusenig,N. E. (1988) J.Cell.Biol.106. 761-771
191.
de Morais, S. M. F. , Wilkinson, G. R. , Blaisdell, J. , Nakamura, K. , Meyer, U. A. & Goldstein, J. A. (1994) J. Biol. Chem.269, 15419-15422
192.
Andersson, T. , Miners, J. O. , Veronese, M. E. , Tassaneeyakul, W. , Meyer, U. A. & Birkett, D. J. (1993) Br. J. Clin. Pharmac.36, 521-530
193.
Hiramatsu, M. , Kumagai, Y. , Unger, S. E. , Cho, A. K. (1990) J. Pharmacol. Expt. Ther.254, 521-527 .
194.
Chu, T. , Kumagai, Y. , DiStefano, E. W. , Cho, A. K. (1996) Biochem. Pharmacol.51, 789-796 .
195.
McCann, U. D. & Ricaurte, G. A. (1991) Brain Res.545, 279-282 .
196.
Kumagai, Y. , Schmitz, D. A. , Cho, A. K. (1992) Xenobiotica22, 395-403 .
197.
Marrs, T.1993Pharmacol & Therapeutics58 No 1 p 51-66
198.
Johnson, M. K.1982Rev in Biochem Tox4 p 141-212
199.
Honnegger, P. & Richelson E.1976Brain Res109 No7 p 335-354
200.
Kingston, S. T.et al.1997Human & Exp. Tox.16 No7 p 381-381
201.
Friedman, H. , Shivers, S. C. & Klein, T. W. (1994). In Immunotoxicology and Immunopharmacology eds. Dean, J. H. , Luster, M. I. , Munson, A. E. & Kimber, I pp. 303-322. New York: Raven Press
202.
Schwarz, H. , Blanco, F. J. & Lotz M. (1994) Journal of Neuroimmunology55, 107-115
203.
Jeon, Y. J. , Yang, K. H. , Pulaski, J. T. , & Kaminski, N. E. (1996) Molecular Pharmacology50, 334-341
204.
Simpson, MG. , Wyatt, I. , Jones, HB. , Gyte, AJ. , Widdowson, PS. and Lock, EA (1996) Neurotoxicology, 17, 471-480 .
205.
Wyatt, I. , Farnworth, M. , Gyte, AJ. and Lock, EA. (1997) Arch Toxicol.71, 668-676 .
206.
Sedlak,J and Lindsay, RH. (1968) Anal. Biochem.25, 192-205 .
207.
Wyatt, I. , Gyte, AJ. , Mainwaring, G. , Widdowson, PS. and Lock EA (1996) Arch Toxicol.70, 380-389 .
208.
Simpson, M. G. , Wyatt, I. , Jones, H. B. , Gyte, A. J. , Widdowson, P. S. & Lock, E. A. (1996) Neurotoxicology.17, 471-480 .
209.
Widdowson, P. S.Wyatt, I. , Gyte, A. , Simpson, M. G. & Lock, E. A. (1996) Toxicol. & Appl. Pharmacol.136, 138-145 .
210.
Sturgess, N. C. , Wilkinson, E. L. & Lock, E. A. (1997) Hum. & Exp. Toxicol.16, 383-383 .
211.
Cheng, B. and Mattson, M. P. (1991) Neuron7, 1031-1041 .
212.
Mattson, M. P. , Kumar, K. N. , Wang, H. , Cheng, B. and Michaelis, E. K. (1993) J. Neurosci.13, 4575-4588 .
213.
Houle, J. D. and Ye, J. H. (1997) Neurorport8(3), 751-755 .
214.
Chambeerlain, M. P. , Lock, E. A. , Rimmel, B. A. & Reed, C. J. (1998) Arch. Toxicol. (in press)
215.
Sturgess, N. C. , Wilkinson, E. L. & Lock, E. A. (1997) Hum. Exp. Toxicol.16: 383-383 .
216.
Rosenberg, L. , et al. , (1991) J. Natl. Cancer Inst.83, 355-358 .
217.
Boolbol, S. K. , et al. , (1996) Cancer Res.56, 2556-2560 .
218.
Wallace, H. M. & Walker, L. (1997) Eur. J. Clin. Pharmacol.52, Suppl. A111-A111
219.
Seglen P. O. (1976)Methods Cell Biol13, 29-83
220.
Juillerta, Met al (1997) Toxicology In Vitro11, 57-693
221.
Hamilton, G.et al (1995) Human and Experimental Toxicology15, 153-153
222.
Munday, R. (1992) Chem. Biol. Inter.82: 165-219 .
223.
Blair, J. A. , Waterfield, C. W. , Lightfoot, R. M. , York, M. and Turton, J. A. (1997) Hum. Exp. Tox.16: 403-403 .
224.
Lapre, J. A. & Van der Meer, R. (1992)Carcinogenesis13, 41-44
225.
Rafter, J. J. , Child, P. , Anderson, A. M. , Alder, R. , Eng, V. & Bruce, B. R. (1987) Am.J.Clin.Nutr.45, 559-563
226.
Rafter, J. J. , & Branting, C. (1991) Eur.J.Cancer Prev.1, 49-54
227.
Armstrong, B. & Doll, R. (1975) Int.J.Cancer15, 617-631
228.
Venturi, M. , Hambly, R. J. , Glinghammar, B. , Rafter, J. J. & Rawland, I. R. (1997) Carcinogenesis18, 2353-2359
229.
Pinto, M. , Robine-Leon, S. , Appay, M.et al. (1983) Biol. Cell.47, 323-330 .
230.
Peterson, M. D. & Mooseker M. S. (1993) J.Cell Science.105, 445-460 .
231.
Martin, F. L. , Carmichael, P. L. , Crofton-Sleigh, C. , Venitt, S. , Phillips, D. H. & Grover, P. L. (1996)Cancer Res.56, 5342-5346 .
232.
Martin, F. L. , Venitt, S. , Carmichael, P. L. , Crofton-Sleigh, C. , Stone, E. M. , Cole, K. J. , Gusterson, B. A. , Grover, P. L. & Phillips, D. H. (1997) Carcinogenesis18, 2299-2305 .
233.
Henderson, B. E. , Ross, R. K. and Pike, M. C. (1993) Science259: 633-638 .
234.
Kuiper, G. G. J. M. , Enmark, E. , Pelto-Huikko, M. , Nilsson, S and Gustafsson, J.-A. (1996) Proc. Natl. Acad. Sci. USA93: 5925-5930 .
235.
Mocarelli, P. (1997) Dioxin '97. 17th International Symposium on Chlorinated Dioxins and Related Compounds. Indianapolis, Indiana, USA, & Personal Communication.
236.
Lewis, D. F. V. (1996) Cytochromes P450 Structure, Function and Mechanism.Taylor & Francis, London .
237.
Gibson, G. G. & Skett, P. (1994) Introduction to Drug Metabolism.Chapman & Hall, London .
238.
Bertazzi, P. A. & di Domenico, A. (1994) In Dioxins and Health ed. Arnold Schecter . Plenum Press, New York . pp 587-632
239.
Bertazzi, P. A. , Zochetti, C. , Guercilena, S. , Consonni, D. , Tironi, A. , Landi, M. , & Pesatori, A. C. (1997) Epidemiology Vol 8., No. 6. pp 646-652
240.
Lewis, D. F. V. & Lee-Robichaud, P. (1998) J. Steroid Biochem. Molec. Biol., IN press
241.
Salzman, A. L. (1995) New Horiz.3(2), 352-364
242.
Simon, L. , Warren, I. & Dayan, A. D. (1997) Dig. Dis. Sci. 42(7), 1519-1523
243.
Mellstrom, B. , Alvan, G. , Bertilsson, L. , Potter, W. Z. , Sawe, J. & Sjoqvist, F. (1982) Clin. Pharmacol. Ther.32, 664-667 .
244.
Olesen, O. V. & Linnet, K.Drug Met. Disp. (1997) 25, 740-744 .
245.
Crewe, H. K. , Lennard, M. S. , Tucker, G. T. , Woods, F. R. & Haddock, R. E.Br. J. Clin. Pharmacol. (1992) 34, 262-265 .
246.
Schulz, P. , Dick, P. , Blascke, T. F. & Hollister, L.Clin. Pharmacokinet. (1985) 10, 257-268 .
247.
Ghahramani, P. , Davies, S. J. C. , Yeo, W. W. , Jackson, P. R. , Lennard, M. S. , Tucker, G. T. & Ramsay, L. E.Br. J. Clin. Pharmacol. (1998) In press.
248.
Felton, J. S. , Kinze, M. G. , Shen, N. H. , Andersen, B. D. , Djeldanes, L. F. and Hatch, F. T. (1986) Environ. Health Perspec.67, 17-24 .
249.
Lin, D. , Kaderlik, K. R. , Turesky, R. J. , Miller, D. W. , Lay, Jr, J. O. and Kadlubar, F. F. (1992) Chem. Res. Toxicol.5, 691-697 .
250.
Crosbie, S. J. , Gooderham, N. J. , Murray, S. , Taylor, G. W. and Boobis, A. R. (1997) Hum, & Exp. Toxicol., 16, 59-59 .
251.
Frandsen, H. (1997) Carcinogenesis, 18, 1555-1560 .
252.
Zhao, K. , Murray, S. , Davies, D. S. , Boobis, A. R. and Gooderham, N. J. (1994) Carcinogenesis, 15, 1285-1288 .
253.
Frandsen, H ,, Grivas, S. , Andersson, R. , Dragsted, L. , Larsen, J. C. (1992) Carcinogenesis, 13, 629-635 .
254.
Warner, A. E. (1996) Clinics in Chest Medicine.17(1): 125-135 .
255.
Hawton, K. , Ware, C. , Mistry, H. , Hewitt, J. , Kingsbury, S. , Roberts, D. , and Weitzel, H. (1995). Why patients choose paracetamol for self-poisoning and their knowledge of its dangers . British Medical Journal, 310, 164-164
256.
Hawton, K. , Ware, C. , Mistry, H. , Hewitt, J. , Kingsbury, S. , Roberts, D. , and Weitzel, H. (1996). Paracetamol self-poisoning, characteristics, prevention and harm reduction . British Journal of Psychiatry, 168, 43-48
257.
Smith, A. G. , Clothier, B. , Robinson, S. , Scullion, M. J. , Carthew, P. , Edwards, R. , Luo, J. L. , Lim, C. K. & Toledano, M (1998) Molec. Pharmacol.153, 52-61 .
258.
Sinclair, P. , Gorman, N. , Dalton, T. , Walton, H. S. , Bement, W. J. , Sinclair, J. F. , Smith, A. G. , Nebert, D. W. (1998) Biochem. J.329, 149-153 .
259.
Lui, J. , Lui, Y. , Barter, R. A. & Klaassen, C. D. (1995) J. Pharmacol. Exp. Ther.273 (2), 977-985
260.
Ikushiro, S. , Emi, Y. & Iyanagi, T. (1995) Arch. Biochem. Biophys.324 (2), 267-272
261.
Hippeli, S & Elstner, E. F. (1997) Z. Naturforsch.52c, 555-563 .
262.
Reed, C. J. (1993) Drug Metab Rev.25, 173-206 .
263.
Young, J. (1981) Fund Appl Toxicol.1, 309-312 .
264.
Kilgour, J. Det al. (1998) Toxicol Met (In Press).
265.
Sai, K. , Takagi, A. , Urnemura, T. , Hasegawa, R. & Kurokawa Y. (1991) Jpn. J. Cancer. Res.82, 165-169
266.
Floyd, R. A. , Watson, J. J. , Wong, P. K. , Altmiller, D. H. & Rickard, R. C. (1986) Free Rad. Res. Commun.1, 163-172
267.
Singh, N. P. , McCoy, M. T. , Tice, R. R. & Schneider, E. L. (1988) Exp. Cell Res.175, 184-191
268.
J. A. Timbrell , V. Seabra and C. J. Waterfield (1995), Gen. Pharmac.26: 453-462 .
269.
C. S. Lieber and L. M. De Carli . (1989), Alcohol and Alcoholism24: 197-211 .
270.
J. Chem and G. C. Farrell . (1996), J. Gastroenterol. Hepatol.11: 870-877 .
271.
Control of Pesticides Regulations 1986 (COPR) (SI 1986/1510). ISBN 0-11-067510-X
272.
Plant Protection Products Regulations 1995 (PPP) (SI 1995/887). ISBN 0-11-052865-4
273.
The Registration Handbook - available from Pesticides Safety Directorate
274.
United States Environmental Protection Agency (1993). Pesticide Reregistration Rejection Rate Analysis. EPA783-R-93-004
275.
Van den Heuvel M. J , Clark D. G. , Fielder R. J , Koundakjian P. P , Oliver G. J. A , Pelling D , Tomlinson N. J and Walker A.P (1990). The international validation of a fixed dose procedure as an alternative to the classical LD50 test . Food Chem. Tox., 28, 469-482 .
276.
Ireland,J. S. , Mukku, V. R. , Robison,A. K. & Stance, G. M. (1980) Biochem. Pharmacol.29, 1469-1474
277.
Routledge,E. J. & Sumpter,J. P. (1996) Environ.Toxicol.Chem.15, 241-248
278.
Messina, M. J. , Persky, V. , Setchell, K. D. & Barnes, S. (1994) Nutr. Cancer21, 113-131 .
279.
Moser, A. R. , Luongo, C. , Gould, K. A. , McNeley, M. K. , Shoemaker, A. R. & Dove, W. F. (1995) Eur. J. Cancer31A, 1061-1064 .
280.
Cassidy, A (1996) Proceedings of the Nutrition Society55, 399-412
281.
Ruíz-Ramírez L , Gracia-Mora I , Moreno-Esparza R , Díaz D , Gasque L , Huerta L , Mayet L , Ortiz V and Lomeli C (1991) J. Inorganic Biochemistry43: 615-615 .
282.
DeVizcaya-Ruiz A , Ruíz-Ramírez L , Kelland LR , Orr RM and Dobrotta M (1998) 89th Annual Meeting of the American Association for Cancer Research. New Orleans, Louisiana, USA.
283.
Huber KR , Sridhar R , Griffith EH , Amma EL and Roberts J (1987) Biochimica Biophysica Acta915: 267-276 .
284.
Von Sonntag C.The chemical basis of radiation biology, Taylor and Francis, London , 1987.
285.
Ruiz-Ramirez, Let al. (1995) J Inorg Biochem59: 207-207 .
286.
Aaseth J , and Norseth T Copper . Handbook on the Toxicology of Metals, 2nd ed.Friberg L , Nordberg GF , and Vouk V (1986) ed. Elsiever : pp233-248.
287.
Chukhlovin, A. B. , Tokalov, S. V. , Yagunov, A. S. & Zharskaya, v. D. (1996) Trace Elem and Electrol13: 37-41 .
288.
Evans, G. W. & Wiederanders, R. E. (1967) Am J Physiol213: 1183-1185 .
289.
Scheinberg, I. H.et al. (1987) N Engl J Med, 317: 209-213 .
290.
Jones MM , Basinger MA & Tarka MP (1980) Res Comm Chem Pathol Parmacol27: 571-577
291.
Deray G and Jacobs C (1995) Radiocontrast nephrotoxicity, a review . Invest Radiol30: 221-225
292.
Morcos SK , Epstein FH , Haylor J , Dobrota M (1996) Aspects of contrast media nephrotoxicity . Eur J Radiol23: 178-184 .
293.
Kerr, J. F. R. , Wyllie, A. H. , Currie, A. R. (1972). Br J Cancer, 26, 239-257 .
294.
Rudin C. M. & Thompson C. B. (1997) Annu. Rev. Mod.48, 267-281 .
295.
Ogasawara J. , Watanabe-Fukunaga R. , Adachi M. , Matsuzawa A. , Kasugai T. , Kitamura Y. , et al (1993) Nature, 364, 806-809 .
296.
Nagata S. (1997) Cell, 88, 355-365 .
297.
Minchin, R. F. (1995) Acetylation of p-aminobenzoylglutamate, a folic acid catabolite, by recombinant human N-acetyltransferase and U937 cells . Biochem. J.307, 1-3 .
298.
Stanley, L. A. , Mills I. G. & Sim, E. (1997) Localisation of polymorphic N-acetyltransferase (NAT2) in tissues of inbred mice . Pharmacogenetics7, 121-130 .
299.
Murray, G. I. , Taylor, M. C. , McFadyen, M. C. E. , McKay, J. A. , Greenlee, W. F. , Burke, M. D. & Melvin, W. T. (1997) Tumour-specific expression of cytochrome P450 CYP1B1 . Cancer Res. 57, 3026-3031 .
